Investing.com -- Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:RECI) more than doubled its peak sales forecast for rare disease drug Isturisa to above €1.2 billion, while keeping its 2027 ...
Investing.com -- RWE AG (ETR:RWEG) on Wednesday reaffirmed its full-year earnings and dividend guidance after posting steady ...
Investing.com-- Bitcoin fell on Wednesday, extending recent losses as an improvement in risk appetite, on progress towards reopening the U.S. government, spurred little buying in cryptocurrency ...
Following its October guidance downgrade, PVA TePla confirmed its full-year 2025 outlook, expecting sales between €235-255 million and EBITDA of €25-30 million.
The net balance of German firms forecasting a rise in business activity fell to +14% in October, down from +21% in June when confidence had reached its highest level since early 2022. This places ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback